Heart Rhythm Daily - Day 2, 2008 - (Page 2)

Robert Fishel, MD. Sudden Cardiac Death (SCD) is a major healthcare problem, and identifying those who are at risk is a signiﬁcant challenge. Microvolt T Wave Alternans™ (MTWA) is an electrocardiographic phenomena associated with increased risk of ventricular tachyarrhythmias and SCD. “In my practice, I use MTWA testing for primary prevention ICD candidates (LVEF ≤ 35%) when the patient or family is reluctant to undergo ICD implantation without additional proof of risk. In such cases, a positive MTWA result can be an effective ‘call to action’. I also ﬁnd MTWA to be useful in the clinical decision-making process for patients with a borderline EF, history of unexplained syncope or non-sustained ventricular arrhythmias, particularly in those with LV dysfunction or a prior myocardial infarction.” ACC/AHA/ESC Class IIa Guideline - Level of Evidence A REIMBURSEMENT INCLUDES: Medicare, BCBS*, CIGNA, Aetna & Humana www.cambridgeheart.com 888.CAM.WAVE *Check with your local provider. Microvolt T-Wave Alternans™ and Spectral Analytic Method™ are trademarks of Cambridge Heart, Inc. Copyright 2008, Inc. All rights reserved. Come Visit us at Booth Number 1829 http://www.cambridgeheart.com http://www.cambridgeheart.com

Table of Contents Feed for the Digital Edition of Heart Rhythm Daily - Day 2, 2008

Contents Town Hall Meetings Live Cases Board Review

Heart Rhythm Daily - Day 2, 2008

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.